PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GenScript Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

GenScript Launches GenPlus™ Next-Generation Gene Synthesis Technology, Achieving Monthly Gene Synthesis Capacity of 100 Mbp - GenScript has launched a new GenPlus™ Next-Generation Gene Synthesis service, which offers unmatched capacity and cost-efficiency for custom gene synthesis - GenScript.com
GenScript Launches GenPlus™ Next-Generation Gene Synthesis Technology, Achieving Monthly Gene Synthesis Capacity of 100 Mbp

 

NewswireToday - /newswire/ - Piscataway, NJ, United States, 2014/02/27 - GenScript has launched a new GenPlus™ Next-Generation Gene Synthesis service, which offers unmatched capacity and cost-efficiency for custom gene synthesis - GenScript.com. 1548:HK

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GenScript, the world’s largest provider of synthetic genes, has launched a new GenPlus™ Next-Generation Gene Synthesis service, which offers unmatched capacity and cost-efficiency for custom gene synthesis.

Building upon over a decade of experience as the leading gene synthesis supplier in the US, GenScript has developed a new breakthrough technology: GenPlus™ Next-Generation Gene Synthesis. GenPlus™ combines the powers of parallel synthesis and automation to achieve a production capacity of over 100 million base-pairs per month, while maintaining GenScript’s commitment to providing 100% sequence fidelity and research-ready deliverables.

“We are very excited to launch this new platform of next generation gene synthesis. It catapults the global capacity of gene synthesis into a new level that has never before been reached,” said Frank Zhang, Ph.D., the CEO of GenScript. “We invite the world’s life science and biomedical research community to partner with us to explore the new research opportunities that are opened up with this unprecedented gene synthesis capacity.”

GenPlus™ offers an efficient high-capacity process that brings down the cost for research projects which require high-volume synthesis of hundreds or thousands of unique DNA sequences. As such, GenPlus™ expands researchers’ access to powerful research strategies. Large gene variant libraries enable efforts to engineer enzymes, metabolic circuits, genomes, and entirely new organisms. Rational design or random mutagenesis of DNA sequences can be used to systematically probe structure-function relationships and gene regulatory mechanisms. As a breakthrough in gene synthesis technology, GenPlus™ promises to spur innovation in disease therapeutics, agricultural technology, and energy, and to deepen our understanding the fundamental principles of biological systems.

About GenScript

Founded in 2002, GenScript (genscript.com) is a leading biology CRO specializing in customized biology research services including gene and peptide synthesis, protein expression, antibody generation and drug discovery/development. GenScript is headquartered in Piscataway, NJ, with subsidiaries in Europe, Japan, and China all dedicated to providing biology research services to 86 countries worldwide.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GenScript Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


GenScript Launches GenPlus™ Next-Generation Gene Synthesis Technology, Achieving Monthly Gene Synthesis Capacity of 100 Mbp

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

GenScript | GenPlus™
Publisher Contact: Sally Wang - GenScript.com 
732-885-9188 sallyw[.]genscript.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GenScript Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GenScript Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)